744197-23-7 Usage
General Description
Methyl 3-piperidin-4-ylbenzoate is a chemical compound with the molecular formula C15H19NO2. It is derived from the esterification of 3-piperidin-4-ylbenzoic acid with methanol. methyl 3-piperidin-4-ylbenzoate is commonly used in the pharmaceutical industry as an intermediate for the synthesis of various drugs, particularly antipsychotic and antidepressant medications. It possesses sedative, analgesic, and anesthetic properties, making it suitable for the development of central nervous system drugs. Methyl 3-piperidin-4-ylbenzoate is considered a valuable building block in organic synthesis and drug discovery due to its versatile reactivity and potential pharmacological applications.
Check Digit Verification of cas no
The CAS Registry Mumber 744197-23-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,4,4,1,9 and 7 respectively; the second part has 2 digits, 2 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 744197-23:
(8*7)+(7*4)+(6*4)+(5*1)+(4*9)+(3*7)+(2*2)+(1*3)=177
177 % 10 = 7
So 744197-23-7 is a valid CAS Registry Number.
744197-23-7Relevant articles and documents
20-HETE FORMATION INHIBITORS
-
Paragraph 0357-0360; 0395; 0396, (2020/08/23)
This disclosure provides novel heterocyclic compounds and methods for inhibiting the enzyme CYP4. Further disclosed methods include: a method of inhibiting the biosynthesis of 20-hydroxyeicosatetraenoic acid (20-HETE) in a subject in need thereof and a method of producing neuroprotection and decreased brain damage by preventing cerebral microvascular blood flow impairment and anti-oxidant mechanisms in a subject experiencing or having experienced an ischemic event.
TRIAZOLOPYRIDINE AND TRIAZOLOPYRIMIDINE INHIBITORS OF MYELOPEROXIDASE
-
Paragraph 00320, (2016/06/01)
The present invention provides compounds of Formula (I): wherein A and R1 are each as defined in the specification, and compositions comprising any of such novel compounds. These compounds are myeloperoxidase (MPO) inhibitors and/or eosinophil peroxidase (EPX) inhibitors, which may be used as medicaments.
